Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This study will examine the long-term safety and efficacy of Deferasirox in patients with
sickle cell disease and iron overload from repeated blood transfusions.